Hospital
Geneva General Hospital INC.
Geneva General Hospital INC. was paid $12.45M by Medicaid between Jan 2018 and Dec 2024, across 212 billing codes. Its largest line is 99283, emergency room visit (moderate) — 11% of everything it billed.
33Billing provider infoGENEVA GENERAL HOSPITAL INC.
GENEVA, NY 14456
GENEVA, NY 14456
33aNPI1952418352assigned 08/23/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$12.45M
24GClaims383,285
24DCodes billed212
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in New York
Rank by total paid#74 of 231
Median peer was paid$561K
This provider vs. median22×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official JOHNSON, PAMELA controls 13+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,178 | $9K | |
| 2019 | 25,346 | $507K | |
| 2020 | 73,535 | $1.72M | |
| 2021 | 82,591 | $2.59M | |
| 2022 | 81,272 | $2.83M | |
| 2023 | 72,764 | $2.50M | |
| 2024incomplete | 45,599 | $2.30M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 11% | 10,890 | 10,429 | $1.33M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 10% | 10,325 | 9,696 | $1.28M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 8.5% | 8,736 | 8,350 | $1.06M |
| G0378 | Hospital observation service, per hour | 4.6% | 381 | 369 | $576K |
| 96361 | Intravenous infusion, hydration; each additional hour | 4.5% | 5,782 | 5,116 | $554K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 4.0% | 9,904 | 8,323 | $493K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 3.5% | 981 | 979 | $433K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 3.2% | 4,393 | 4,268 | $401K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3.1% | 2,481 | 2,424 | $384K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.9% | 2,682 | 2,616 | $361K |
| 80053 | Comprehensive metabolic panel | 2.9% | 27,192 | 24,499 | $357K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 2.5% | 756 | 745 | $316K |
200 more codes
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 2.1% | 3,215 | $264K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.9% | 1,866 | $240K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.4% | 3,094 | $172K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 1.3% | 1,564 | $161K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1.3% | 1,744 | $160K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 1.2% | 270 | $154K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 1.2% | 984 | $149K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.2% | 4,386 | $148K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.1% | 637 | $143K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1.1% | 4,207 | $138K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.1% | 13,129 | $136K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 1,603 | $124K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 1,567 | $123K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 900 | $113K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 4,405 | $111K |
| 80061 | Lipid panel | <1% | 11,463 | $109K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 815 | $105K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 1,779 | $101K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 1,504 | $97K |
| 87486 | <1% | 2,078 | $94K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 29,442 | $87K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 8,689 | $83K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,468 | $82K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 3,255 | $64K |
| 88142 | <1% | 2,304 | $62K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 6,997 | $62K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 474 | $59K |
| 84439 | <1% | 5,760 | $53K | |
| 76770 | <1% | 527 | $51K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 786 | $50K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 1,267 | $48K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 377 | $48K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 333 | $47K |
| 82607 | <1% | 3,659 | $46K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 2,599 | $46K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 5,605 | $43K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,436 | $41K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,803 | $41K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 7,113 | $41K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 6,913 | $39K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 2,068 | $38K |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | <1% | 32 | $33K |
| 87581 | <1% | 2,080 | $32K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 1,063 | $31K |
| 74018 | <1% | 970 | $31K | |
| 87507 | <1% | 179 | $30K | |
| 87631 | <1% | 564 | $29K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 396 | $29K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 1,568 | $27K |
| 36415 | Collection of venous blood by venipuncture | <1% | 15,725 | $25K |
| 86780 | <1% | 2,236 | $23K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,808 | $21K |
| 82728 | <1% | 1,598 | $20K | |
| 93971 | <1% | 353 | $20K | |
| 82746 | <1% | 1,512 | $19K | |
| 71045 | Radiologic examination, chest; single view | <1% | 3,318 | $18K |
| 86803 | <1% | 1,439 | $17K | |
| 83735 | <1% | 5,067 | $17K | |
| 87070 | <1% | 1,935 | $17K | |
| 83550 | <1% | 2,167 | $16K | |
| 80076 | <1% | 2,510 | $16K | |
| 81003 | <1% | 9,493 | $16K | |
| 86900 | <1% | 915 | $15K | |
| 82043 | <1% | 1,632 | $14K | |
| 87186 | <1% | 2,462 | $13K | |
| 84702 | <1% | 1,275 | $13K | |
| 76830 | Ultrasound, transvaginal | <1% | 193 | $13K |
| 84146 | <1% | 743 | $13K | |
| 83540 | <1% | 2,387 | $12K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 93 | $12K |
| 87340 | <1% | 1,107 | $11K | |
| 87210 | <1% | 2,954 | $11K | |
| 83655 | <1% | 788 | $11K | |
| 86850 | <1% | 803 | $11K | |
| 86140 | <1% | 1,703 | $10K | |
| 83880 | <1% | 511 | $10K | |
| 84403 | <1% | 339 | $10K | |
| 82948 | <1% | 2,106 | $10K | |
| 72100 | <1% | 298 | $10K | |
| 82570 | <1% | 1,841 | $9K | |
| 84703 | <1% | 3,618 | $9K | |
| 85027 | <1% | 2,370 | $9K | |
| 73630 | <1% | 555 | $9K | |
| 99490 | Ccm add 20min | <1% | 437 | $8K |
| 81025 | <1% | 3,457 | $8K | |
| 86901 | <1% | 911 | $8K | |
| 85610 | <1% | 3,329 | $8K | |
| 76536 | <1% | 134 | $8K | |
| 73610 | <1% | 551 | $7K | |
| 12001 | <1% | 39 | $7K | |
| 76642 | <1% | 139 | $7K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 3,599 | $7K |
| 73562 | <1% | 330 | $6K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 842 | $6K |
| 73130 | <1% | 317 | $6K | |
| 0012A | <1% | 180 | $5K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 3,996 | $5K |
| 86038 | <1% | 569 | $5K | |
| 85652 | <1% | 2,347 | $5K | |
| 83690 | <1% | 4,343 | $5K | |
| 73030 | <1% | 296 | $4K | |
| 81001 | <1% | 1,361 | $4K | |
| 86762 | <1% | 300 | $4K | |
| 82784 | <1% | 337 | $4K | |
| 82248 | <1% | 882 | $3K | |
| 97162 | <1% | 42 | $3K | |
| 86376 | <1% | 174 | $3K | |
| 0011A | <1% | 174 | $3K | |
| 73110 | <1% | 159 | $3K | |
| 90715 | <1% | 213 | $2K | |
| 84484 | <1% | 3,032 | $2K | |
| 94727 | <1% | 25 | $2K | |
| 76801 | <1% | 46 | $2K | |
| 82150 | <1% | 967 | $2K | |
| 94060 | <1% | 13 | $2K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 14 | $2K |
| 82105 | <1% | 182 | $2K | |
| 83516 | <1% | 146 | $2K | |
| 86618 | <1% | 104 | $2K | |
| 93017 | <1% | 13 | $2K | |
| 86255 | <1% | 174 | $2K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 39 | $2K |
| 96367 | <1% | 33 | $2K | |
| 86787 | <1% | 163 | $2K | |
| 82550 | <1% | 623 | $2K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 13 | $1K |
| 85730 | <1% | 1,342 | $1K | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 96 | $1K |
| 83001 | <1% | 79 | $1K | |
| 88304 | <1% | 56 | $1K | |
| 84153 | <1% | 65 | $1K | |
| 76870 | <1% | 24 | $1K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 19 | $1K |
| 86364 | <1% | 152 | $1K | |
| 73502 | <1% | 39 | $1K | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 480 | $1K |
| 83525 | <1% | 105 | $1K | |
| 82077 | <1% | 33 | $1K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 2,315 | $982.66 |
| 86431 | <1% | 167 | $897.15 | |
| 77066 | Tomosynthesis, mammo | <1% | 13 | $817.32 |
| 83605 | <1% | 1,419 | $811.56 | |
| 85379 | <1% | 928 | $804.07 | |
| 87040 | <1% | 554 | $785.46 | |
| 80074 | <1% | 34 | $779.73 | |
| 86480 | <1% | 12 | $639.06 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 2,163 | $604.63 |
| 0352U | <1% | 12 | $584.06 | |
| 84402 | <1% | 14 | $536.73 | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 25 | $504.68 |
| 82950 | <1% | 107 | $480.71 | |
| 71271 | <1% | 12 | $443.28 | |
| 87625 | <1% | 13 | $389.19 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,056 | $376.25 |
| J2704 | Injection, propofol, 10 mg | <1% | 95 | $371.35 |
| 84481 | <1% | 27 | $371.01 | |
| 82652 | <1% | 14 | $360.58 | |
| 0002A | <1% | 13 | $352.28 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 324 | $345.86 |
| 86256 | <1% | 29 | $316.48 | |
| 84436 | <1% | 77 | $311.85 | |
| 99000 | <1% | 64 | $300.64 | |
| 82681 | <1% | 13 | $293.96 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 970 | $287.23 |
| 87641 | <1% | 13 | $279.77 | |
| 86336 | <1% | 25 | $276.15 | |
| 86765 | <1% | 12 | $270.08 | |
| J3490 | Unclassified drugs | <1% | 133 | $270.07 |
| 82670 | <1% | 13 | $268.44 | |
| 84550 | <1% | 64 | $253.04 | |
| 82677 | <1% | 12 | $243.80 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,939 | $228.95 |
| 86665 | <1% | 12 | $227.66 | |
| 86308 | <1% | 64 | $221.58 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 4,280 | $192.25 |
| 74019 | <1% | 12 | $182.54 | |
| 0001A | <1% | 12 | $145.23 | |
| 73140 | <1% | 14 | $137.44 | |
| 73590 | <1% | 12 | $135.58 | |
| 96376 | <1% | 309 | $120.55 | |
| 94729 | <1% | 12 | $106.79 | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 15 | $90.09 |
| 85014 | <1% | 28 | $89.02 | |
| 84100 | <1% | 59 | $88.71 | |
| 80178 | <1% | 14 | $76.34 | |
| 84460 | <1% | 13 | $69.32 | |
| 85018 | <1% | 30 | $63.26 | |
| 80143 | <1% | 13 | $51.69 | |
| 80179 | <1% | 12 | $51.69 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 480 | $43.31 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 389 | $35.61 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 134 | $19.05 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 310 | $16.55 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 341 | $5.68 |
| J2060 | Injection, lorazepam, 2 mg | 0% | 17 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 17 | $0.00 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 0% | 44 | $0.00 |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 78 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 28 | $0.00 |
| 72125 | Computed tomography, cervical spine; without contrast material | 0% | 26 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialJOHNSON, PAMELA (TREASURER/CFO)
| Provider | Location | Paid |
|---|---|---|
| Soldiers & Sailors Memorial Hospital | Penn Yan, NY | $13.18M |
| Geneva General Hospital, INC | Geneva, NY | $4.00M |
| Amazin Recovery Treatment Services LLC | Dundalk, MD | $2.55M |
| Amazin Recovery Treatment Services LLC | Dundalk, MD | $1.03M |
| Citywide Health Corporation | Pikesville, MD | $879K |
| Decatur Dental Services, INC. | Bluffton, IN | $708K |
| Geneva General Hospital, INC. | Geneva, NY | $452K |
| Citywide Health Corporation | Pikesville, MD | $440K |
| Soldiers & Sailors Memorial Hospital | Penn Yan, NY | $280K |
| Soldiers and Sailors Memorial Hospital | Penn Yan, NY | $257K |
| Geneva General Hospital INC | Geneva, NY | $229K |
| Citywide Behavioral Health | Baltimore, MD | $121K |
| Geneva General Hospital | Geneva, NY | $115K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.